As of 4:00pm ET
| -0.02 / -0.21%|
Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease. Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS, approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults, and AGGRASTAT a reversible GP IIb/IIIa inhibitor indicated for use in patients with acute coronary syndrome. The company was founded on December 12, 1986 and is headquartered in Vancouver, Canada.
|William L. Hunter||President, Chief Executive Officer & Director|
|Sheila M. Grant||Chief Operating Officer|
|Jennifer Archibald||Chief Financial Officer|
|Karim F. Lalji||Chief Commercial Officer|
|Steen Juul-Möller||Medical Director-Europe|